Teleflex (TFX) Asset Writedowns and Impairment (2009 - 2025)

Teleflex (TFX) posted Asset Writedowns and Impairment of $100.0 million for Q3 2025, up 1131.98% on a QoQ basis from $8.1 million in Q2 2025.

Teleflex (TFX) Asset Writedowns and Impairment (2009 - 2025) Analysis & Trends

Teleflex's Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $100.0 million for Q3 2025.

Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $100.0 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $108.1 million (up 1280.1% YoY) and the FY2025 annual result came in at $108.1 million, up 1280.1% from the prior year.
Asset Writedowns and Impairment was $100.0 million for Q3 2025 at Teleflex, up from $8.1 million in the prior quarter.
Across five years, Asset Writedowns and Impairment topped out at $100.0 million in Q3 2025 and bottomed at $1.5 million in Q1 2022.
A 4-year average of $20.7 million and a median of $6.2 million in 2021 frame the typical range for Asset Writedowns and Impairment.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn
10	Teleflex	5.80 Bn	5.49 Bn	307.43 Mn

Download Data